Companies of the medical and pharmaceutical sectors are especially popular nowadays as their corporate earnings peaked on the back of the pandemic. However, BioMarin Pharmaceutical still cannot share the success of pharmaceutical giants. Meanwhile, from the technical point, its shares have never logged a serious fall over the recent 5 years but have been trading firmly sideways. The range-bound market has created strong support. Moreover, when analyzing charts of the stock dynamic, it becomes clear that the stock is set for a robust bullish trend in the short term. At the same time, financial records of the company are not too rosy but not too gloomy either.
Centene Corporation, another firm in the medical sector, is on track to gain popularity among Wall Street investors. Its stock quotes have formed a kind of a Triangle pattern which is about to be broken upwards. This indicates bullish prospects in the equity market. Hypothetically, investors could earn profits as high as 62%. One more weighty argument in favor of buying Centene Corporation’s shares is a positive fundamental outlook.
This company is not directly involved in the medical sector but it belongs to the broader healthcare sector. eHealth Inc. deals with human life and health insurance. Since 2016, the stock dynamic has developed a steady uptrend which gives investors hope that no slump will happen in the near time. On top of that, the company can boast buoyant sales that make its stock more attractive. All in all, investors can rely on solid returns of nearly 60%. Besides, the fundamental profile of eHealth Inc. is also convincing.
You may wonder why AT&T, a telecommunications company, is included in the list. In the meantime, high-tech stocks are trading in the red. Nevertheless, the stock of the US largest provider of telephone services has been trading firmly upwards since 2002. Currently, investors are shifting focus away from telecommunications companies. However, charts of AT&T stock prove that it is set to continue a long-term bullish trend. Thus, investors reckon their profits could surge up to 48%.